Stock BLEVF BELEAVE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Beleave Inc.

Equities

BLEVF

CA0775611084

Market Closed - OTC Markets
Other stock markets
 01:21:53 2024-04-04 pm EDT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Beleave Inc. -.--% -.--%
2020 Beleave Inc. Appoints Bill Panagiotakapoulos as Chief Restructuring Officer CI
2020 Hegedus Consulting Services Inc. agreed to acquire Substantially All of the Assets from Beleave Inc. (CNSX:BE). CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Alternative Medicine

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BELEAVE INC. Stock Beleave Inc.
 553 - - - - -
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
 6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
 4.46B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
 3.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
 3.2B - -
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
 2.6B - - - - -
  1. Stock Market
  2. Equities
  3. BLEVF Stock
  4. Charts Beleave Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW